CM
PTPI

CM Management’s Petros Pharmaceuticals PTPI Stock Holding History

CM Management’s Portfolio PTPI Stock Details PTPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-400
Closed -$200K – 93
2021
Q3 		$200K Hold
400
– – 0.15% 87
2021
Q2 		$313K Buy
400
+220
+122% +$176K 0.23% 81
2021
Q1 		$168K Hold
180
– – 0.12% 80
2020
Q4 		$198K Buy
+180
New +$169K 0.18% 76

Other funds holding PTPI

SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

CM Management's PTPI Position: Q4 2021 in Review

CM Management sold out of Petros Pharmaceuticals (PTPI) in Q4 2021, closing a stake of 400 shares — an estimated $200K sold.

CM Management first reported a position in PTPI in Q4 2020 and held it in 4 quarters. The position peaked at $313K in Q2 2021. 18 funds tracked by Wall St. Rank hold PTPI as of Q4 2021.

  • CM Management reported no remaining Petros Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
  • CM Management sold 400 Petros Pharmaceuticals shares in Q4 2021, an estimated $200K.
  • CM Management first reported a position in Petros Pharmaceuticals in Q4 2020 and held it in 4 quarters.
  • CM Management's Petros Pharmaceuticals position peaked at $313K in Q2 2021.
  • 18 funds tracked by Wall St. Rank held Petros Pharmaceuticals as of Q4 2021.

Based on CM Management's 13F filing for Q4 2021, filed 2 Feb 2022.